Profil
Wayne Saville worked as Vice President-Clinical Oncology at Xencor, Inc. from 2015 to 2020.
He also worked as Vice President-Clinical Development at Tocagen, Inc. Dr. Saville received his undergraduate and doctorate degrees from Northwestern University.
Ehemalige bekannte Positionen von Wayne Saville
| Unternehmen | Position | Ende |
|---|---|---|
| XENCOR, INC. | Corporate Officer/Principal | 01.04.2020 |
| FORTE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Wayne Saville
| Northwestern University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| XENCOR, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
